Maede Salehi

Maede Salehi

Auto-generated profile, based on publicly available information

Maede Salehi

Department of Oral Medicine, Dental Research Center, Mazandaran University of Medical Sciences, Sari, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2022 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
TMTahere Molania
Tahere Molania
ASAli Malekzadeh Shafaroudi
Ali Malekzadeh Shafaroudi
MSMajid Saeedi
Majid Saeedi
MMMahmood Moosazadeh
Mahmood Moosazadeh
FVFaeze Valipour
Faeze Valipour
MSMaede Salehi
Maede Salehi
Background & objective: The use of herbal medicines to treat common oral diseases increases rapidly. Recurrent aphthous stomatitis is one of the most common oral mucosal diseases, which has an unclear etiology and could lead to severe pain and dysfunction. Cinnamaldehyde is a major component of cinnamon bark oil. Biological properties of cinnamaldehyde, such as antioxidant, antitumor, antifungal, cytotoxic, and anti-mutational characteristics, have been identified. Considering the prevalence of recurrent aphthous stomatitis and the importance of using herbal resources for treatment, the present study aimed to evaluate the effect of mucosal adhesive patches containing Cinnamaldehyde on minor recurrent aphthous stomatitis lesions. Material & methods: In this randomized, double-blind clinical trial, patients were divided into two groups. The intervention group received three daily mucosal adhesive patches to be used in the morning, afternoon, and night. The control group also did the same with a placebo. To evaluate the healing and determine the diameter of the lesions, patients were clinically examined on days zero, 3, 5, and 7. The VAS scale evaluated pain at baseline and after each meal for seven days. The Fisher's exact test, t-test, Shapiro Wilk test, Friedman test, and the Mann–Whitney test were used to analyze the data using the SPSS 20 software. Results: There was no statistically significant difference in the mean diameter of the inflammatory lesion and pain intensity in the two groups in the baseline (p > 0.05). However, the ulcer size was significantly reduced in the cinnamaldehyde group on the third, fifth, and seventh days of the study. Except for baseline, the mean pain intensity significantly decreased in the cinnamaldehyde group compared to the placebo group (p < 0.05). Conclusion: Cinnamaldehyde mucoadhesive patches effectively reduced and improved aphthous lesions and pain intensity in patients and can be considered a treatment for RAS. Registration number: IRCT20180312039060N2—First registration date: 20/07/2018. The present study was registered as a retrospective study.

11 August 2021 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
TMTahereh Molania
Tahereh Molania
ASAli Malekzadeh Shafaroudi
Ali Malekzadeh Shafaroudi
MTMehdi Taghavi
Mehdi Taghavi
HEHodis Ehsani
Hodis Ehsani
MMMahmood Moosazadeh
Mahmood Moosazadeh
MSMaede Salehi
Maede Salehi
Background: Cardiovascular Disease (CVD) is one of the leading causes of mortality and morbidity and significantly impacts the health-related quality of life. Oral infections have been linked to cardiovascular diseases such as thrombosis, cardiac infarction, stroke, and peripheral vascular disease. This study aims to evaluate the effects of oral health on the quality of life in cardiovascular patients.Methods: The oral health-related quality of life was measured using the OHIP-14 questionnaire. Demographic information, questions regarding smoke consumption, wearing removable prostheses, nine questions regarding xerostomia, and the existence of other systemic diseases were asked from 240 participants with cardiovascular diseases. The DMFT index was clinically examined in each patient. Also, the Plaque, Gingival, and Sulcular Bleeding Indices were measured on the Ramfjord teeth. Data analysis was conducted using SPSS version 16. The independentttest, Mann–Whitney test, the variance analysis, and the Kruskal–Wallis test were used to compare variables in the present study. Also, regression models were used to eliminate the effect of confounding variables.Results: Gender variables, removable prosthesis, xerostomia, DMFT, and SBI were the main determinants of quality of life in CVD patients. The mean ADD-OHIP14 of participants in the study was calculated at 21.34 ± 17.40, and the SC-OHIP14 was 6.11 ± 5.07. The mean OHRQoL was higher in females than in males, and this difference was statistically significant. OHRQoL was significantly lower in patients wearing a removable prosthesis than in those without one. The relationship between age and xerostomia was significant in this study, and patients with xerostomia had a lower quality of life than those without xerostomia. Also, the mean DMFT index in subjects with xerostomia was 23.69 ± 7.76, which was statistically significant compared to those without xerostomia.Conclusion: Cardiovascular patients experienced a decreased OHRQoL. Prevention or treatment of these problems seems to justify improving the quality of life in these patients.

1 January 2016
Verified
Journal Article
Open access
NBNeda Babaee
Neda Babaee
HHHamed Hosseinkazemi
Hamed Hosseinkazemi
MPMahdi Pouramir
Mahdi Pouramir
OBOveis Khakbaz Baboli
Oveis Khakbaz Baboli
MSMaede Salehi
Maede Salehi
MMMahsa Mehryari
Mahsa Mehryari
Recurrent aphthous stomatitis (RAS) is the most common inflammatory ulcerative condition of oral cavity. The aim of this study was to compare the levels of the salivary Malondialdehyde (MDA) and total antioxidant capacity (TAC) and blood parameter in RAS versus healthy controls. This case-control study consisted of 28 patients with RAS and 28 age and sex -matched control without RAS. Cell blood count was assessed by sysmex system, serum iron and total iron binding capacity was measured by standard laboratory kit and for ferritin ELISA kit was utilized. Salivary TAC and MDA level determined using FRAP and TBARS method respectively. Statistical analysis was performed using SPSS Version 21, chi-square test was used to compare proportions, and student’s t-test and Mann Whitney U-test were used for the comparison of quantitative variables Salivary MDA level was significantly higher (p<0.001) and TAC level was significantly lower (p<0.042) in RAS as compared with the control group. Also, serum ferritin level was significantly higher in RAS patients (p<0.008). These findings indicate the alteration of oxidant/antioxidant status was observed in recurrent aphthous stomatitis, may be also associated with changing several hematinic parameters in this study. The finding maybe helpful to clarify the etiologies of RAS and possibely to improve the management or preventive options.

13 May 2023 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
TMTahereh Molania
Tahereh Molania
JAJafar Akbari
Jafar Akbari
ABAmirhossein Babaei
Amirhossein Babaei
ALAnahita Lotfizadeh
Anahita Lotfizadeh
MMMahmood Moosazadeh
Mahmood Moosazadeh
MSMaede Salehi
Maede Salehi
Background: Aphthous stomatitis is one of the most common oral mucosal diseases. Due to the commonness of recurrent aphthous stomatitis and considering the anti-inflammatory, analgesic, and tissue regenerative properties of atorvastatin and the lack of a study on the effect of statins on minor recurrent aphthous stomatitis, this study investigates the effect of atorvastatin mucoadhesive tablets as a topical treatment on reduction of symptoms and duration of this disease. Methods: This study is a randomized, double-blinded clinical trial. Patients were divided into two groups, atorvastatin and, placebo; each of the patients received three mucoadhesive tablets daily in the morning, noon, and night. Finally, the patients were examined on days 0 (baseline), 3, 5, and 7 to determine the diameter of the inflammatory halo. The VAS scale was used to evaluate pain intensity for up to 7 days after each meal. The data was entered into SPSS 24 software and analyzed. Results: The halo diameter did not significantly differ between the two groups on baseline (P > 0.05). However, on the study’s third, fifth, and seventh days, the difference between the two groups was remarkable, so in the atorvastatin group, the size of the lesions decreased in shorter healing time (P < 0.05). In addition, the patient’s pain intensity (VAS) also showed a significant decrease in the atorvastatin group except on the first, second, and seventh days of the study (P < 0.05). Conclusion: Atorvastatin mucoadhesive tablets effectively reduce the pain of patients with minor recurrent aphthous stomatitis and reduce the size and healing time of the lesions, so their application should be considered in treating minor recurrent aphthous stomatitis. The present study was approved by the Medical Ethics Committee of Mazandaran University of Medical Sciences with the ethics code IR.MAZUMS.REC.1400.8346. Also, this study received code IRCT20170430033722N4.

31 March 2023 in Dental and Medical Problems
Verified
Journal Article
Open access
TMTahereh Molania
Tahereh Molania
MSMaede Salehi
Maede Salehi
HEHodis Ehsani
Hodis Ehsani
MMMahmood Moosazadeh
Mahmood Moosazadeh
FNFatemeh Niksolat
Fatemeh Niksolat
MSMohammad Ebrahimi Saravi
Mohammad Ebrahimi Saravi
Sjögren's syndrome (SS) is a common systemic autoimmune disease that affects oral health, and consequently oral health-related quality of life (OHRQoL) due to the involvement of exocrine glands. The present study aimed to evaluate the oral health-related quality of life and oral health indicators in patients with SS in comparison with healthy individuals. In the case and control groups (45 patients and 45 healthy individuals), questions about demographic data, other systemic disorders, medications, the years of infection, xerostomia, as well as inquiries about the quality of life (Oral Health Impact Profile-14 - OHIP-14) were asked. The patients were evaluated clinically, and oral health indicators, including the plaque index (PI), the gingival index (GI), the sulcus bleeding index (SBI), and the number of decayed, missing and filled teeth (DMFT) were assessed on the Ramfjord teeth. Unstimulated saliva samples from both groups were obtained and weighed. The data was analyzed using IBM SPSS Statistics for Windows, v. 24.0. Quantitative variables were compared between the case and control groups with the use of the independent t test or their nonparametric equivalent (the Mann-Whitney test). The comparison of the quantitative variables between the study groups showed a statistically significant difference in the OHRQoL scores (p = 0.037) and the unstimulated saliva flow rate (p = 0.002) between the case and control groups. Also, there was a statistically significant difference in the DMFT index between patients with primary and secondary SS in the case group (p = 0.048). The lower OHRQoL of patients with SS requires more attention and follow-up to solve periodontal and dental problems in this group of patients.

26 September 2025 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
TMTahereh Molania
Tahereh Molania
MSMajid Saeedi
Majid Saeedi
KMKatayoun Morteza-Semnani
Katayoun Morteza-Semnani
RNReza Negarandeh
Reza Negarandeh
AHAbolfazl Hosseinnataj
Abolfazl Hosseinnataj
IHIman Haghani
Iman Haghani
Candidiasis is humans’ most common oral fungal infection and is a major opportunistic fungal infection with significant morbidity and mortality, particularly in immunocompromised patients, highlighting its clinical importance worldwide. This study investigated the antifungal effect of nystatin, fluconazole, cinnamaldehyde, and nano-cinnamaldehyde on candidiasis. In this in vitro study, nano-cinnamaldehyde formulations were prepared using span60, tween60, and cholesterol for fabrication of noisome vesicles by the ethanol injection technique. The optimum formulation (cinnosome 2) was prepared with 100 mg Span 60, 100 mg Tween 60, and 50 mg cholesterol with 5 ml of ethanol. The size and particle dispersion index (PDI) of nanoparticles were measured using Dynamic Light Scattering technique, the zeta potential was measured using Zetasizer Nano ZS, and the amount of nano-cinnamaldehyde release was measured using dialysis by USP2 dissolution device. Twenty Candida species isolates, including C. albicans, Pichia kudriavzevii, Nakaseomyces glabratus, and C. tropicalis, were obtained from clinical samples, cultured in malt extract agar medium, and fungal suspensions were prepared in RPMI medium. For antifungal evaluation, the broth microdilution test was performed, and the MIC was read after 24 h. Differences between groups were determined by Mann-Whitney and Kruskal-Wallis tests at a significance level of 0.05 via GraphPad Prism 6 and SPSS 22 software. Among the five niosomal formulations, the optimal nanoparticle showed a mean size of 228.75 ± 2.38 nm, PDI of 0.24 ± 0.01, zeta potential of -10.87 ± 1.09 mV, and encapsulation efficiency (EE%) of 66.71 ± 3.93%. The size of the nanoparticles varied from 137 to 297 nm among the formulations, and the particle size increased significantly with the amount of cholesterol. Nystatin, fluconazole and nano-cinnamaldehyde showed the best antifungal property with the lowest geometric mean (GM), 0.177 µg/mL, 0. 308 µg/mL and 0.554 µg/mL, respectively, followed by cinnamaldehyde (2.732 µg/mL) and carrier (2.828 µg/mL). According to the MIC50 and MIC90 values, it was found that nystatin, fluconazole, nano-cinnamaldehyde, cinnamaldehyde and carrier have the highest to the lowest antifungal property, respectively. Findings revealed that nano-cinnamaldehyde exhibited excellent antifungal activity against more than 65% of Candida isolates, indicating its promise as a potent alternative for managing oral candidiasis. Not applicable.